SEASON 2: Dysmenorrhea affects 83% of women in India with Abhishek Mohan, Hempstreet

In this episode, we sit down with Abhishek Mohan, the Founder and CEO of Hempstreet, India's pioneering player in the medicinal cannabis sector. With a vast network of 60,000 ayurvedic practitioners nationwide, Hempstreet leads the way from research to retail in this burgeoning field. 

Our conversation with Abhishek delves into a range of topics, starting with the staggering impact of dysmenorrhea, affecting 83% of Indian women. Abhishek sheds light on Hempstreet's groundbreaking clinical trials, emphasizing their crucial significance in today's landscape. 

We explore Hempstreet's unique approach of integrating ayurvedic principles into cannabis products, particularly in offering relief for menstrual cramps. Additionally, we touch upon the recent attention surrounding Meftal spas, dissecting the media hype versus medical reality, as well as the concerning lack of menstrual cramp management products available in the Indian market. Abhishek shares his learnings and insights into the changing landscape of women's health. 

This episode is a must-listen for anyone interested in understanding menstrual health, dysmenorrhea, the potential of cannabis in women's health, and gaining insights into the Meftal Spas controversy.

DISCLAIMER: The content presented in this podcast is not intended to serve as a substitute for professional medical advice, diagnosis, or treatment. It's always advisable to consult with your doctor or qualified healthcare provider for personalized guidance.